About Elfin Drugs
Elfin Drugs is a Healthcare company based in Sahibzada Ajit Singh Nagar (India) founded in 2011 by Dinesh Agarwal. It manufactures pharmaceutical tablets, capsules, injectables, and syrups for global markets. It operates on a B2B model. The company has 19 employees. Its chief executive, as recorded, is Dinesh Agarwal. Its Indian entity Elfin Drugs Private Limited reported revenue of ₹21.23 Cr. Elfin Drugs offers products and services including Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops. Its focus areas include Pharmaceuticals, Drug Manufacturing, Tablets and Capsules and Syrups and Drops. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Elfin Drugs Private Limited is a pharmaceutical manufacturer based in Mohali, Punjab, India, with facilities in Baddi. They produce and export a wide range of products including tablets, capsules, injectables, syrups, and ointments, following WHO-GMP guidelines for quality. The company serves international clients in countries like Georgia and Iraq, focusing on effective, clinically tested medicines through advanced manufacturing processes.
- Headquarters Sahibzada Ajit Singh Nagar, India
- Employees 19
- Founders Dinesh Agarwal
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website elfinpharma.in
- Legal Name Elfin Drugs Private Limited
- Date of Incorporation 25 Apr, 2005
- Jurisdiction Mohali, Punjab, India
- Annual Revenue₹21.23 Cr
FY 2024 · +15% YoY
- Net Profit₹21.1 Lakh
FY 2024 · 1% margin
- EBITDA₹1.68 Cr
FY 2024 · 8% margin
- Employee Count19
Associated legal entities of Elfin Drugs
Elfin Drugs operates through Elfin Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elfin Drugs Private Limited CIN U24231PB2005PTC028300 | Active | 25 Apr 2005 | Mohali, Punjab | ₹21.2 Cr | 19 | 2 | View details |
Products & Services of Elfin Drugs
Elfin Drugs offers a comprehensive portfolio of products and services, including Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops.
Tablet for managing pain and inflammation effectively.
Suspension for treating bacterial infections.
Drops providing essential vitamins and minerals.
Board of directors of Elfin Drugs Private Limited (Elfin Drugs)
Elfin Drugs Private Limited is the primary company behind Elfin Drugs. The board of Elfin Drugs Private Limited currently have 2 directors; the longest-serving is Dilpreet Singh, appointed in 2005. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilpreet Singh DIN 01446357 | Director | 25 Apr 2005 | 21 yrs 6 mo | Elfin Drugs Private Limited |
| Surinder Jit Kaur DIN 08487523 | Director | 19 Jun 2019 | 7 yrs 4 mo | Elfin Drugs Private Limited |
People of Elfin Drugs
1 people are tracked at Elfin Drugs (1 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Dinesh Agarwal | Founder, CEO | Leadership |
Complete people profiles for Elfin Drugs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Elfin Drugs
Figures of Elfin Drugs Private Limited, the primary company behind Elfin Drugs, for FY 2024. Revenue was ₹21.23 Cr (+15% year on year). Net profit was ₹21.1 Lakh (1% margin). EBITDA was ₹1.68 Cr (8% margin). Revenue has grown at a compounded annual rate of +20% over three years and +18% over five years.
- ₹21.23 CrRevenue · FY 2024 · +15% YoY
- ₹21.1 LakhNet profit · 1% margin
- ₹1.68 CrEBITDA · 8% margin
- ₹70.5 LakhPaid-up capital
- 19Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elfin Drugs Private Limited are on its company page.
Detailed financial statements for Elfin Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Elfin Drugs
Elfin Drugs has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Elfin Drugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elfin Drugs
The website of Elfin Drugs (elfinpharma.in) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 6.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elfin Drugs
Elfin Drugs was founded in 2011.
Elfin Drugs is headquartered in Sahibzada Ajit Singh Nagar, India. It is registered at Sahibzada Ajit Singh Nagar, Punjab, India.
Dinesh Agarwal is the CEO of Elfin Drugs, as recorded in our data. They have also founded this company.
Elfin Drugs has 19 employees.
The primary company behind Elfin Drugs, Elfin Drugs Private Limited, reported revenue of ₹21.23 Cr for FY 2024, up 15% year on year.
Elfin Drugs Private Limited is a pharmaceutical manufacturer based in Mohali, Punjab, India, with facilities in Baddi. They produce and export a wide range of products including tablets, capsules, injectables, syrups, and ointments, following WHO-GMP guidelines for quality. The company serves international clients in countries like Georgia and Iraq, focusing on effective, clinically tested medicines through advanced manufacturing processes.
Elfin Drugs's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Elfin Drugs offers Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops.
Elfin Drugs operates through Elfin Drugs Private Limited.
The legal entities of Elfin Drugs currently have 2 directors, including Dilpreet Singh, Surinder Jit Kaur.